BugSeq

BugSeq leads clinical bioinformatics in consortium (@Ginkgo, @JumpcodeG , @planetinnovate , @TGenResearch , and more) developing end-to-end metagenomic solution for @EU_HaDEA. See our announcement here: bugseq.com/news/2025/02/2…

This program is supported by @GenomeCanada and @GenomeBC through the Genomic Applications Partnership Program. Learn more about the program in the announcement.

Through this effort, the team will validate BugSeq’s bioinformatic platform to improve patient outcomes and strengthen Canadian biosecurity and pandemic preparedness.

BugSeq is delighted to partner with @UBC to improve detection, surveillance and early identification of emerging respiratory pathogens across Canada.

Hypervirulent Klebsiella pneumoniae is an emerging concern in clinical microbiology. Read how BugSeq was used to characterize the first cases of hypervirulent K. pneumoniae in Nebraska: doi.org/10.1128/asmcr.…

In case you missed it, the recording of the BugSeq + @nanopore webinar is now available on demand! Discover how Dr. Georgios Kitsios used BugSeq for respiratory metagenomics in the @UPMC ICU: nanoporetech.com/resource-centr…

→ docs.bugseq.com/blog/2026/01/0…

Clinical interpretation and reporting of next-generation sequencing assays is challenging. Check out our recent blog post to learn about how BugSeq leverages machine learning and configurable thresholds to implement evidence-based reporting for your NGS assay.🧬

Don't miss out! Join us on January 14th for an insightful webinar with Dr. Kitsios of @UPMC. Learn how BugSeq delivers rapid, actionable, and highly accurate results for respiratory #metagenomics in critical care settings. nanoporetech.com/about/events/w…

2025 was an amazing year for sequencing in microbiology! Check out some of our favorite publications from the past year. 🦠 docs.bugseq.com/blog/2025/12/2…

🚨 BugSeq now supports both EUCAST (new) and CLSI (already supported) breakpoints for the prediction of #AMR. This expansion ensures greater accuracy and global applicability in determining resistance. Get in touch for early access to EUCAST breakpoints on your account.

Check out this recent article by Dr. Jose Alexander, @AdventHealth, on the power of BugSeq and how it is enabling NGS-based pathogen detection and resistance characterization in their healthcare system! linkedin.com/pulse/amr-geno…

At #AMPath2025? Here is one more reason why you need to drop by booth 447 to discuss bioinformatics with our team of experts!

🚨 New Publication 🚨 Check out this paper from @MSKCancerCenter, where BugSeq empowers the center's infection control team to launch an active C. auris surveillance program. WGS informs infection control interventions → doi.org/10.1016/j.jmol… #InfectionPrevention #Cauris

Meet BugSeq at #IDWeek2025 - Booth 1329! See how our bioinformatics platform empowers clinical microbiology labs and drives clinically validated assays with customizable reporting thresholds.

Pathogen surveillance relies on fast and accurate data analysis, but NGS pipelines can be complex and resource-intensive. Our event will show how @bugseq simplifies analysis for organism identification, AMR detection, and outbreak tracking. Sign up here: event.on24.com/wcc/r/5066485/…

Ever wonder how BugSeq is used to identify bacteria, characterize #AMR and track outbreaks in hospitals and the community? Tune in on Sep 29 to hear from Wes Hottel, Bioinformatics Scientist, State Hygienic Laboratory, The University of Iowa: event.on24.com/wcc/r/5066485/…

Register for our upcoming webinar on September 29: event.on24.com/wcc/r/5066485/…

C. difficile is the most frequent cause of infectious diarrhea in hospitals and long-term care facilities. Locher et al. used BugSeq to evaluate transmission within @VCHhealthcare (doi.org/10.1016/j.mime…). Want to learn more?

NGS has improved pathogen surveillance, but complex bioinformatics pipelines can hold many labs back. Join our upcoming webinar to learn how @bugseq makes advanced microbial ID, AMR detection, and outbreak tracking accessible to every lab. Register here: event.on24.com/wcc/r/5066485/…

🚨 New blog - Bringing Precision Medicine to the ICU: Insights from BugSeq Grant Recipient Dr. Kitsios (@UPMC). Read how @KitsiosMd is leveraging @nanopore metagenomics to revolutionize diagnosis and management of ventilator-associated pneumonia: docs.bugseq.com/blog/2025/08/1…